BIO
Price
$295.34
Change
+$5.91 (+2.04%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
7.67B
48 days until earnings call
EMBC
Price
$14.97
Change
+$0.48 (+3.31%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
847.45M
109 days until earnings call
Interact to see
Advertisement

BIO vs EMBC

Header iconBIO vs EMBC Comparison
Open Charts BIO vs EMBCBanner chart's image
Bio-Rad Laboratories
Price$295.34
Change+$5.91 (+2.04%)
Volume$400
Capitalization7.67B
Embecta
Price$14.97
Change+$0.48 (+3.31%)
Volume$25.07K
Capitalization847.45M
BIO vs EMBC Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. EMBC commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Hold and EMBC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BIO: $289.43 vs. EMBC: $14.49)
Brand notoriety: BIO and EMBC are both not notable
BIO represents the Medical/Nursing Services, while EMBC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIO: 68% vs. EMBC: 47%
Market capitalization -- BIO: $7.67B vs. EMBC: $847.45M
BIO [@Medical/Nursing Services] is valued at $7.67B. EMBC’s [@Pharmaceuticals: Other] market capitalization is $847.45M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileEMBC’s FA Score has 2 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • EMBC’s FA Score: 2 green, 3 red.
According to our system of comparison, EMBC is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while EMBC’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 4 bearish.
  • EMBC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIO is a better buy in the short-term than EMBC.

Price Growth

BIO (@Medical/Nursing Services) experienced а -1.44% price change this week, while EMBC (@Pharmaceuticals: Other) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +24.78%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

Reported Earning Dates

BIO is expected to report earnings on Oct 23, 2025.

EMBC is expected to report earnings on Dec 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($7.67B) has a higher market cap than EMBC($847M). BIO has higher P/E ratio than EMBC: BIO (26.10) vs EMBC (10.20). BIO YTD gains are higher at: -11.896 vs. EMBC (-27.327). BIO has less debt than EMBC: BIO (1.41B) vs EMBC (1.55B).
BIOEMBCBIO / EMBC
Capitalization7.67B847M906%
EBITDA656MN/A-
Gain YTD-11.896-27.32744%
P/E Ratio26.1010.20256%
Revenue2.55BN/A-
Total Cash1.37BN/A-
Total Debt1.41B1.55B91%
FUNDAMENTALS RATINGS
BIO: Fundamental Ratings
BIO
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
48
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIOEMBC
RSI
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
70%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVLVX15.190.13
+0.86%
Cullen Value I
NWJFX114.460.95
+0.84%
Nationwide NYSE Arca Tech 100 Idx InsSvc
DIVHX29.250.18
+0.62%
Cutler Equity Fund
AFNAX26.490.13
+0.49%
Bahl & Gaynor Income Growth A
OANLX83.710.31
+0.37%
Oakmark Select Institutional

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
+0.48%
A - BIO
71%
Closely correlated
+2.60%
DHR - BIO
69%
Closely correlated
-0.21%
TMO - BIO
68%
Closely correlated
+1.02%
MTD - BIO
66%
Closely correlated
+1.51%
ILMN - BIO
64%
Loosely correlated
+1.68%
More

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with NEOG. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then NEOG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+1.26%
NEOG - EMBC
37%
Loosely correlated
+0.35%
WAT - EMBC
37%
Loosely correlated
+3.32%
RVTY - EMBC
36%
Loosely correlated
+2.81%
MTD - EMBC
36%
Loosely correlated
+1.51%
BIO - EMBC
35%
Loosely correlated
+0.48%
More